Subject: Re: Is GLP-1 the next big pharma cash cow?
Since I don't have a subscription to the FT and could see the article, I thought everyone could.

Depends on how an article is accessed. Sometimes a subscription is required, sometimes the publisher will open the by-subscription site for nonsubscribers (WSJ sometimes does this for some articles on weekends), sometimes a Google search will bypass the paywall.

Eric Hines